Heavy Ion Particle Therapy in Modern Day Radiation Oncology

IF 2.7 3区 医学 Q2 HEMATOLOGY Hematology-Oncology Clinics of North America Pub Date : 2024-12-17 DOI:10.1016/j.hoc.2024.11.007
Xiaoying Liang PhD , Homan Mohammadi MD , Kathryn C. Moreno MSN, MBA, RN , Chris J. Beltran PhD , Adam L. Holtzman MD
{"title":"Heavy Ion Particle Therapy in Modern Day Radiation Oncology","authors":"Xiaoying Liang PhD , Homan Mohammadi MD , Kathryn C. Moreno MSN, MBA, RN , Chris J. Beltran PhD , Adam L. Holtzman MD","doi":"10.1016/j.hoc.2024.11.007","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":55060,"journal":{"name":"Hematology-Oncology Clinics of North America","volume":"39 2","pages":"Pages 377-397"},"PeriodicalIF":2.7000,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology-Oncology Clinics of North America","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0889858824001527","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
现代放射肿瘤学重离子粒子治疗。
重离子放射治疗是治疗放射耐药实体瘤的新兴技术。与目前的低线性能量转移技术不同,重离子放疗,如碳离子放疗,可以增强与癌症治疗相关的生物效应。前瞻性临床证据已证明该方法在头颈部、胸部、中枢神经系统、胃肠道、盆腔肿瘤和肉瘤等多个疾病部位的可行性和有效性。虽然目前在美洲还没有,但梅奥诊所正在美国建造一个重离子设施,计划于2028年投入临床运行。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
86
审稿时长
6-12 weeks
期刊介绍: Hematology/Oncology Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Under the direction of an experienced guest editor, each issue focuses on a single topic in hematology and oncology, including hemostasis and thrombosis, molecular and cellular basis of hematology, coagulation disorders, and cancers—bone, gastrointestinal, head and neck, lymphomas, neuroendocrine, breast, renal cell, melanoma, and more.
期刊最新文献
Circulating Tumor DNA Assessment in Classic Hodgkin Lymphoma: Ready for Primetime? Selection of a Salvage Regimen for Relapsed or Refractory Classic Hodgkin Lymphoma in the Era of Novel Therapies. Contents Contemporary Management of Dermatofibrosarcoma Protuberans Contemporary Multimodal Management of Primary Retroperitoneal Sarcomas
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1